Day: October 8, 2025

eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market

First-of-its-kind platform brings residential and commercial under one roof, giving UK agents more control, higher earning potential, and global reach eXp Realty Launches UK Commercial Division, Expanding Agent Model Into $10B Market First-of-its-kind platform brings residential and commercial under one roof, giving UK agents more control, higher earning potential, and global reach BELLINGHAM, Wash., Oct. 08, 2025 (GLOBE NEWSWIRE) — eXp Realty®, the largest independent real estate brokerage in the world and a core subsidiary of eXp World Holdings, Inc. (Nasdaq: EXPI), has announced the launch of eXp UK Commercial, expanding the company’s commercial real estate capabilities in one of

Continue Reading

Nilo Therapeutics launches with $101 million Series A financing to advance a new class of medicines targeting neural circuits in immune disease and appoints Kim Seth as Chief Executive Officer

Series A led by The Column Group, DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments NEW YORK, Oct. 08, 2025 (GLOBE NEWSWIRE) — Nilo Therapeutics, a biotechnology company harnessing neural circuits to restore immune homeostasis in disease, launched today with a $101 million Series A financing led by The Column Group (TCG), DCVC Bio, and Lux Capital, with participation from the Gates Foundation and Alexandria Venture Investments. Coinciding with its launch, Nilo announced the appointment of Kim Seth, Ph.D., as Chief Executive Officer and Board director. Founded by world-leading scientists Charles Zuker, Ph.D.

Continue Reading